LIRUM Trademark

Trademark Overview

On Tuesday, May 9, 2023, a trademark application was filed for LIRUM with the United States Patent and Trademark Office. The USPTO has given the LIRUM trademark a serial number of 97926852. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 23, 2024. This trademark is owned by Lirum Therapeutics, Inc.. The LIRUM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for human use for the treatment and prevention of diseases and disorders, namely, oncology, neurodegenerative, ophthalmology, autoimmune, debilitating, degenerative, and infectious diseases and disorders; pharmaceuticals for human use, namely, oncology, neurodegenerative, ophthalmology and autoimmune pharmaceuticals; pharmaceuticals for the treatment of debilitating, degenerative, and infectious diseases

Medical and scientific research, namely, conducting clinical trials for others; consulting services for others in the field of design, planning, implementation, and project management of clinical trials; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals, therapeutics, clinical trials, and studies; testing of pharmaceuticals, biopharmaceuticals, therapeutics, and drugs; research and development of pharmaceuticals, biopharmaceuticals, therapeutics, and drugs; consulting in the field of pharmaceutical, biopharmaceutical, and biotech drug development services; clinical and scientific research and development in the field of pharmaceuticals and biopharmaceuticals; providing medical and scientific research information and data relating to pharmaceuticals, biopharmaceuticals, therapeutics, and medical and scientific research and development; research and development of pharmaceuticals and drug candidates
lirum

General Information

Serial Number97926852
Word MarkLIRUM
Filing DateTuesday, May 9, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for human use for the treatment and prevention of diseases and disorders, namely, oncology, neurodegenerative, ophthalmology, autoimmune, debilitating, degenerative, and infectious diseases and disorders; pharmaceuticals for human use, namely, oncology, neurodegenerative, ophthalmology and autoimmune pharmaceuticals; pharmaceuticals for the treatment of debilitating, degenerative, and infectious diseases
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; consulting services for others in the field of design, planning, implementation, and project management of clinical trials; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals, therapeutics, clinical trials, and studies; testing of pharmaceuticals, biopharmaceuticals, therapeutics, and drugs; research and development of pharmaceuticals, biopharmaceuticals, therapeutics, and drugs; consulting in the field of pharmaceutical, biopharmaceutical, and biotech drug development services; clinical and scientific research and development in the field of pharmaceuticals and biopharmaceuticals; providing medical and scientific research information and data relating to pharmaceuticals, biopharmaceuticals, therapeutics, and medical and scientific research and development; research and development of pharmaceuticals and drug candidates

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLirum Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameLirum Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Friday, May 12, 2023NEW APPLICATION ENTERED
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 9, 2024NON-FINAL ACTION E-MAILED
Friday, February 2, 2024ASSIGNED TO EXAMINER
Friday, February 9, 2024NON-FINAL ACTION WRITTEN
Friday, February 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

lirum pharmaceuticals research development biopharmaceuticals scientific medical field therapeutics clinical trials